Nanochon Receives Significant Investment

cultivate(MD) Capital Funds has made a significant investment into Nanochon, a developer of regenerative cartilage treatments. Nanochon's Chondrograft replaces lost or damaged cartilage and encourages new growth using material and 3D-printed designs that are cost-effective and easy to deploy treatment options.

R. Sean Churchill, MD, MBA,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us